AVITA MED LTD/S (OTCMKTS:AVMXY) was down 0.3% during mid-day trading on Thursday . The company traded as low as $5.87 and last traded at $5.93, approximately 18,743 shares changed hands during trading. A decline of 86% from the average daily volume of 138,699 shares. The stock had previously closed at $5.94.

Several analysts have weighed in on AVMXY shares. ValuEngine cut Zosano Pharma from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Lake Street Capital boosted their target price on AVITA MED LTD/S from $4.00 to $8.00 and gave the stock a “buy” rating in a research report on Friday, April 5th.

The firm’s 50-day moving average is $5.68.

AVITA MED LTD/S Company Profile (OTCMKTS:AVMXY)

Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin.

See Also: Why are trading ranges significant?

Receive News & Ratings for AVITA MED LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA MED LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.